Ignite Creation Date:
2024-05-06 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05174650
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-23
First Post:
2021-11-09
Brief Title:
Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 FusionsRearrangements
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization Data
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Class:
OTHER
Study ID:
ADVANCE_2020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None